AUG 08, 2018 6:31 AM PDT

Cholesterol Pill For Treating A Brutal Lung Disease

WRITTEN BY: Nouran Amin

A brutal lung disease called Pulmonary Alveolar Proteinosis (PAP) is caused by a thick substance known as surfactant that clogs up the air sacs in the lungs. Now, researchers report in Nature Communications that they figured out why this clogging occurs and show that a cholesterol pill referred to as statin may effectively treat this brutal disease. The study serves as hope for PAP patients because current standard treatments are invasive and usually are repeated every time a patients lungs clogs up, essentially affecting their quality of life.

But, investigators at Cincinnati Children's Hospital Medical Center found that the issue is cholesterol. More specifically, the research team have discovered that early studies PAP was linked to a disruption of cellular regulation by a molecule known as granulocyte-macrophage colony stimulating factor (GM-CSF). GM-CSF is needed for the development of mature macrophages that are crucial for removing surfactant. Led, the team found out years ago that PAP is linked to disruption of cell regulation by a molecule called GM-CSF is crucial for the development of fully mature macrophage cells in the lungs, which are needed to clear away used surfactant -- a substance important to lung function -- so that people can breathe.

In the study led by Bruce Trapnell, MD, director of the Translational Pulmonary Science Center, researchers examined PAP patients and mouse models of the disease and uncovered a critical reason behind disruption of cell regulation by GM-CSF which triggers PAP. This is because cell dysregulation reduced the function of macrophage cells to process and clear out cholesterol, causing the levels to build up. This build-up has adversely effects as it contributes to the accumulation of surfactant leading to PAP. "Showing that the pathogenic driver of the disease is disruption of cholesterol homeostasis in these patients will change thinking in the PAP field," explains Trapnell. "Now that we know cholesterol in macrophages is a target for therapeutic development, repurposing statins is a pretty straightforward pharmacological approach for treating people with PAP." A clinical trial is currently being planned.

The research study was supported from the National Institutes of Health/National Heart, Lung, and Blood Institute (R01085453, HL118161, HL136543), and a National Center for Advancing Translational Science grant through the National Heart, Lung, and Blood Institute (HL127672).

 

Source: Cincinnati Children's Hospital Medical Center

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAR 15, 2021
Cell & Molecular Biology
When Sample Temperature Matters: How to Keep Your Cool in the Lab
MAR 15, 2021
When Sample Temperature Matters: How to Keep Your Cool in the Lab
Temperature control is critical to many molecular and cellular experiments, but managing sample temperature requires eit ...
MAR 24, 2021
Drug Discovery & Development
Three Compounds May Be Suitable for SARS-CoV-2
MAR 24, 2021
Three Compounds May Be Suitable for SARS-CoV-2
Researchers have found that that three common antiviral and antimalarial therapeutics may be effective in vitro at targe ...
APR 04, 2021
Drug Discovery & Development
Ion-Pump for Chemotherapy
APR 04, 2021
Ion-Pump for Chemotherapy
Patients of malignant brain tumors experience recurrences even after subsequent treatments. To address this issue, scien ...
APR 21, 2021
Drug Discovery & Development
Dietary Supplement Successfully Treats Mice with Schizophrenia
APR 21, 2021
Dietary Supplement Successfully Treats Mice with Schizophrenia
Researchers from the University of Tokyo have found that betaine, a dietary supplement found in sugar beets, reduces beh ...
MAY 06, 2021
Drug Discovery & Development
Are Hallucinations Necessary for Psychedelics to Treat Depression?
MAY 06, 2021
Are Hallucinations Necessary for Psychedelics to Treat Depression?
Many who work with psychedelics say that hallucinations, or psychedelic experiences, are an integral part of psychedelic ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
Loading Comments...